Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Published:2022-05-16 Issue:5 Volume:5 Page:e2212347
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Chakiryan Nicholas H.¹,Gore L. Robert²,Reich Richard R.²,Dunn Rodney L.³,Jiang Da David⁴,Gillis Kyle A.⁵,Green Elizabeth¹,Hajiran Ali¹,Hugar Lee¹,Zemp Logan¹,Zhang Jingsong¹,Jain Rohit K.¹,Chahoud Jad¹,Spiess Philippe E.¹,Manley Brandon J.¹,Sexton Wade J.¹,Hollenbeck Brent K.³,Gilbert Scott M.¹

Affiliation:

1. Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida

2. Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, Florida

3. Department of Urology, University of Michigan Medical School, Ann Arbor

4. Department of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

5. Department of Urology, University of Iowa Hospitals & Clinics, Iowa City

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2792363/chakiryan_2022_oi_220366_1654704333.6141.pdf

Reference35 articles.

1. NCCN Guidelines Insights: kidney cancer, version 2.2020.;Motzer;J Natl Compr Canc Netw,2019

2. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.;Flanigan;N Engl J Med,2001

3. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.;Mickisch;Lancet,2001

4. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.;Flanigan;J Urol,2004

5. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma.;Rini;J Clin Oncol,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology;Current Oncology;2024-08-22

2. Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database;Current Oncology;2024-08-18

3. Low-Dose Prasugrel vs. Standard-Dose Clopidogrel for Patients Undergoing Percutaneous Coronary Intervention;Circulation Journal;2024-07-09

4. Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?;JNCI: Journal of the National Cancer Institute;2024-05-23

5. First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy;BJU International;2024-04-24